We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+39.52%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$866M
AUM Growth
-$31.6M
Cap. Flow
-$181M
Cap. Flow %
-20.86%
Top 10 Hldgs %
11.15%
Holding
394
New
126
Increased
23
Reduced
100
Closed
121

Top Buys

Rank Stock Value
1
MOG.A icon
Moog Inc Class A
MOG.A
+$8.18M
2
GLNG icon
Golar LNG
GLNG
+$6.78M
3
MOD icon
Modine Manufacturing
MOD
+$6.63M
4
MYRG icon
MYR Group
MYRG
+$6.49M
5
DAN icon
Dana Inc
DAN
+$6.19M

Sector Composition

Rank Sector Weight
1 Industrials 23.17%
2 Technology 23.07%
3 Healthcare 17.28%
4 Energy 12.86%
5 Consumer Discretionary 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPIH
251
Perma-Pipe International
PPIH
$204M
$609K 0.07%
20,421
AVIR icon
252
Atea Pharmaceuticals
AVIR
$379M
$607K 0.07%
+112,866
New +$518K
OVID icon
253
Ovid Therapeutics
OVID
$435M
$600K 0.07%
+270,298
New +$483K
IVR icon
254
Invesco Mortgage Capital
IVR
$776M
$584K 0.07%
+72,293
New +$617K
CPSH icon
255
CPS Technologies
CPSH
$85.6M
$574K 0.07%
153,369
LE icon
256
Lands' End
LE
$361M
$564K 0.07%
+50,203
New +$794K
LCTX icon
257
Lineage Cell Therapeutics
LCTX
$257M
$548K 0.06%
346,615
-95,606
-22% -$161K
TWIN icon
258
Twin Disc
TWIN
$335M
$546K 0.06%
36,248
-16,614
-31% -$281K
PZG icon
259
Paramount Gold Nevada
PZG
$94.4M
$546K 0.06%
+328,997
New +$622K
NPCE icon
260
Neuropace
NPCE
$505M
$543K 0.06%
41,289
-34,511
-46% -$518K
CHRS icon
261
Coherus Oncology
CHRS
$217M
$524K 0.06%
+309,801
New +$550K
ENTA icon
262
Enanta Pharmaceuticals
ENTA
$372M
$517K 0.06%
40,952
GLSI icon
263
Greenwich LifeSciences
GLSI
$191M
$515K 0.06%
+21,430
New +$559K
NRGV icon
264
Energy Vault
NRGV
$522M
$511K 0.06%
154,791
-63,975
-29% -$264K
SHIM icon
265
Shimmick
SHIM
$150M
$508K 0.06%
+138,450
New +$494K
HRTG icon
266
Heritage Insurance Holdings
HRTG
$842M
$495K 0.06%
18,843
-170,113
-90% -$4.49M
UMAC icon
267
Unusual Machines
UMAC
$925M
$479K 0.06%
+38,616
New +$588K
BOF icon
268
BranchOut Food
BOF
$60.5M
$467K 0.05%
+141,645
New +$491K
MRAM icon
269
Everspin Technologies
MRAM
$354M
$451K 0.05%
51,315
-35,197
-41% -$387K
SYPR icon
270
Sypris Solutions
SYPR
$43.7M
$414K 0.05%
+145,420
New +$462K
IDR icon
271
Idaho Strategic Resources
IDR
$449M
$413K 0.05%
12,853
-96,222
-88% -$3.73M
MNPR icon
272
Monopar Therapeutics
MNPR
$736M
$341K 0.04%
6,225
-5,148
-45% -$311K
KRMD icon
273
KORU Medical Systems
KRMD
$176M
$333K 0.04%
77,013
-59,703
-44% -$296K
ACNB icon
274
ACNB Corp
ACNB
$634M
-21,781
Closed -$1.05M
ADPT icon
275
Adaptive Biotechnologies
ADPT
$3.56B
-351,297
Closed -$5.71M

Similar funds

EAM Investors's Q1 2026 Portfolio in Review

As of Q1 2026, EAM Investors held 394 positions worth $866M, down 3.5% from $898M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $181M in Q1 2026, closing 121 positions and reducing 100 holdings. Its most notable exit was Credo Technology Group, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, EAM Investors opened a new position in Moog Inc Class A worth $7.82M.

  • EAM Investors's largest Q1 2026 buy was Moog Inc Class A: 26,715 shares worth $7.82M.
  • EAM Investors added most to Bloom Energy in Q1 2026, an estimated $3.21M increase.
  • EAM Investors's biggest Q1 2026 reduction was Sandisk, cutting an estimated $8.28M.
  • EAM Investors fully exited Credo Technology Group in Q1 2026, selling an estimated $11.3M.
  • EAM Investors's ten largest holdings make up 11% of its $866M portfolio in Q1 2026.
  • EAM Investors opened 126 new positions and closed 121 in Q1 2026.
  • EAM Investors's portfolio value fell 3.5% quarter-over-quarter to $866M.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.